
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Environmental Health Sciences [R. P., M. G., J. R., R. F., L. A.], Laboratory of General Epidemiology [E. N., C. L. V.], Istituto di Ricerche Farmacologiche Mario Negri, 20157 Milan, Italy; Department of Occupational and Environmental Health, University of Milan, Italy [D. A., P. C.]; Institute of Medical Statistics, University of Milan, Italy [C. L. V.]; and Laboratory of Environmental Hygiene and Industrial Toxicology, "S. Maugeri" Foundation, Istituto di Ricovero e Cura a Carattere Scientifico, Pavia, Italy [A. B., G. M., C. M.]
Exposure to airborne polycyclic aromatic hydrocarbons (PAHs) in 65 employees (40 sampled both in summer and winter, 15 sampled in summer only, and 10 sampled in winter only) with no occupational exposure to PAHs was assessed by measuring: personal exposure to pyrene, urinary excretion of 1-hydroxypyrene (1-OHP), and benzo(a)pyrene diol epoxide adducts to hemoglobin (BPDE-Hb). Overall, office employees were exposed to significantly higher levels of pyrene in winter (4.54 ± 2.35 ng/m3, mean ± SD) than in summer (1.67 ± 1.92 ng/m3, mean ± SD; P < 0.001), but no such seasonal variability was observed in 1-OHP excretion. Tobacco smoking was the major determinant of 1-OHP excretion. BPDE-Hb adducts were measured by gas chromatography-mass spectrometry as benzo(a)pyrene tetrols (BPT) released from adducted hemoglobin. In the 65 employees analyzed, mean BPT levels ± SD were higher in winter (0.14 ± 0.38 fmol/mg Hb) than summer (0.031 ± 0.022 fmol/mg Hb). This difference was not statistically significant, probably because of the small proportion of subjects with detectable adducts (11% in summer and 16% in winter). BPDE-Hb adducts were not significantly associated with sex, age, diet, smoking habits, or with pyrene levels and 1-OHP excretion. This is the first report providing reference BPDE-Hb adduct values for the general population not occupationally exposed to environmental PAHs and shows a tendency to seasonal variability, with higher BPT levels in winter when environmental PAHs are also high.
This article has been cited by other articles:
![]() |
E. Gyorffy, L. Anna, K. Kovacs, P. Rudnai, and B. Schoket Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts Mutagenesis, January 1, 2008; 23(1): 1 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. CAMPO, M. BURATTI, S. FUSTINONI, P. E CIRLA, I. MARTINOTTI, O. LONGHI, D. CAVALLO, and V. FOA Evaluation of Exposure to PAHs in Asphalt Workers by Environmental and Biological Monitoring. Ann. N.Y. Acad. Sci., September 1, 2006; 1076: 405 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. RUCHIRAWAT, P. NAVASUMRIT, D. SETTACHAN, and H. AUTRUP Environmental Impacts on Children's Health in Southeast Asia: Genotoxic Compounds in Urban Air. Ann. N.Y. Acad. Sci., September 1, 2006; 1076: 678 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Culea, O. Cozar, and E. Culea PAHs in Cigarette Smoke by Gas Chromatography-Mass Spectrometry Indoor and Built Environment, June 1, 2005; 14(3-4): 283 - 292. [Abstract] [PDF] |
||||
![]() |
J. Y. Kim, S. S. Hecht, S. Mukherjee, S. G. Carmella, E. G. Rodrigues, and D. C. Christiani A Urinary Metabolite of Phenanthrene as a Biomarker of Polycyclic Aromatic Hydrocarbon Metabolic Activation in Workers Exposed to Residual Oil Fly Ash Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 687 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Solhaug, M. Refsnes, M. Lag, P. E. Schwarze, T. Husoy, and J. A. Holme Polycyclic aromatic hydrocarbons induce both apoptotic and anti-apoptotic signals in Hepa1c1c7 cells Carcinogenesis, May 1, 2004; 25(5): 809 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Castano-Vinyals, A D'Errico, N Malats, and M Kogevinas Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution Occup. Environ. Med., April 1, 2004; 61(4): e12 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer Carcinogenesis, June 1, 2002; 23(6): 907 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
B C Gladen, T D Zadorozhnaja, N Chislovska, D O Hryhorczuk, M C Kennicutt II, and R E Little Polycyclic aromatic hydrocarbons in placenta Human and Experimental Toxicology, November 1, 2000; 19(11): 597 - 603. [Abstract] [PDF] |
||||
![]() |
G. Scherer, S. Frank, K. Riedel, I. Meger-Kossien, and T. Renner Biomonitoring of Exposure to Polycyclic Aromatic Hydrocarbons of Nonoccupationally Exposed Persons Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 373 - 380. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |